Neurodegenerative disease: Factoring in astrocytes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Protocol for metabolite extraction and sample preparation from primary astrocytes for mass spectrometry-based metabolomic analysis.STAR protocols · 2026
   Article
2. Mesenchymal Stem Cells-based Cell-free Therapy Targeting Neuroinflammation.Aging and disease · 2024
   Review
3. NF-κB as an Inducible Regulator of Inflammation in the Central Nervous System.Cells · 2024
   Review
4. Garcinia morella extract confers dopaminergic neuroprotection by mitigating mitochondrial dysfunctions and inflammation in mouse model of Parkinson's disease.Metabolic brain disease · 2022
   Article
5. Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response.Experimental brain research · 2022
   Article
6. Dysfunctional glia: contributors to neurodegenerative disorders.Neural regeneration research · 2021
   Review
7. Glia in Neurodegeneration: The Housekeeper, the Defender and the Perpetrator.International journal of molecular sciences · 2020
   Review
8. Human iPSC-derived Down syndrome astrocytes display genome-wide perturbations in gene expression, an altered adhesion profile, and increased cellular dynamics.Human molecular genetics · 2020
   Article
9. Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration.Nature neuroscience · 2019
   Article
10. Astrocytic Oxidative/Nitrosative Stress Contributes to Parkinson's Disease Pathogenesis: The Dual Role of Reactive Astrocytes.Antioxidants (Basel, Switzerland) · 2019
    Review
11. Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism.Journal of inherited metabolic disease · 2018
    Review
12. Neuron-astrocyte signaling is preserved in the aging brain.Glia · 2017
    Article
13. Neural Subtype Specification from Human Pluripotent Stem Cells.Cell stem cell · 2016
    Review
14. A Commentary On: "NFκB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer's Disease". A cautionary note regarding C3aR.Frontiers in immunology · 2015
    Article

Corrections and comments

• Comment on
  NFκB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease.2015

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as